Cereno Scientific AB Series B

Research Cereno Scientific AB Series B (CRNO-B) on Bullrun: market cap SEK 1.65B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRNO-B
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencySEK
• Market capSEK 1.65B
• Financial periodQ4 2025
• Net income-SEK 44.71M
• Free cash flow-SEK 47.75M

Valuation Snapshot

latest market cap is SEK 1.65B.

About Cereno Scientific AB Series B

Cereno Scientific AB (publ), a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.

Frequently asked questions

What is Cereno Scientific AB Series B's market cap?

Cereno Scientific AB Series B's market capitalization is SEK 1.65B.

What does Cereno Scientific AB Series B do?

Cereno Scientific AB (publ), a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.